Medical Dialogues

Dynamic Model Predicts Individualized Benefits and Risks of Platelet Transfusion in Preterm Infants with Thrombocytopenia: JAMA

The model showed strong discriminatory performance, with a time-dependent AUC of 0.69 for the prophylaxis strategy and 0.85 ...

I’m an Emergency Medicine Doctor. I’m Terrified About the Future of the American Blood-Donation System.

About a year earlier, the EMS service in Kirkpatrick’s North Carolina county had begun a blood-transfusion program, ...
AHA/ASA Journals

First Aid: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment Recommendations

The International Liaison Committee on Resuscitation conducts continuous reviews of new, peer-reviewed, published first aid ...

DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

IMFINZI® (durvalumab)-based regimen reduced the risk of death by 22% in early gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
HDFN Companion

Study finds iron overload common in infants with Rh-mediated HDFN

Most infants in the study with Rh-linked hemolytic disease were born with high iron levels that can persist for up to a year.